Trials / Completed
CompletedNCT04873089
Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin
RV3278AET0943 Cosmetic Product Efficacy Applied for 8 Weeks in Adults Having Oily and Acne Prone Skin: Comparative Study Versus Not Treated Group
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Pierre Fabre Dermo Cosmetique · Industry
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate, at different times, the RV3278A - ET0943 cosmetic product efficacy after 8 weeks of application on the face (twice-daily application). At T1 (Baseline), T2 (4 weeks) and T3 (8 weeks), the following assessments are performed: * The reduction of the pilosebaceous follicular ostium size in vivo (pores) on the forehead * The clinical evaluation (count of non inflammatory and inflammatory acne lesions, IGA score) of the face * The reduction in visible follicles * The standardized numerical photographs of face and ¾ right and left profile in normal, parallel polarized, cross polarized and UV light * The analysis of the skin lipids of the forehead * The qualitative and quantitative analysis of the sebum and comedones constituents (nose wings) This is a comparative, open-labelled study, on subjects with oily and acne prone skins on the face. Each group includes 18 subjects.
Detailed description
This study is monocentric, comparative versus non-treated group, open-labelled, exploratory, conducted in adults having oily and acne prone skin. The study includes 4 visits for each group, including subjects' selection: * V0: Subjects' selection * V1: Baseline inclusion * V2: 4 weeks, follow-up visit * V3: 8 weeks, study end The maximal study duration is 61 days. The front, temporal areas and nose wings are defined as the study interest areas for superficial samples. The evaluation is at 3 times: T1 baseline, T2 at 4 weeks and T3 at 8 weeks of application of RV3278A formula ET0943 with comparison of each time versus baseline. There are twice-daily applications (morning and evening) of the test product on the face.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cosmetic product | It is a comparative study with two parallel groups of subjects: * Tested group: twice daily application of the cream RV3278A cosmetic product on the whole face * Comparative group: no application of study product or reference product |
Timeline
- Start date
- 2018-09-17
- Primary completion
- 2018-12-21
- Completion
- 2018-12-21
- First posted
- 2021-05-05
- Last updated
- 2021-05-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04873089. Inclusion in this directory is not an endorsement.